期刊文献+

早产儿脑室内出血预防专家共识(2025) 被引量:4

Expert consensus on prevention of intraventricular hemorrhage in preterm infants(2025)
原文传递
导出
摘要 早产儿脑室内出血(IVH)是导致早产儿,特别是出生胎龄<32周早产儿死亡和严重神经系统残疾的重要合并症。近年我国早产儿救治数量大幅增加,极早产儿(出生胎龄≥28~31周)/超早产儿(出生胎龄<28周)的存活率也有很大提升,但是超早产儿的IVH发生率高达48%,而且重度IVH发生率呈逐年上升趋势,显著高于发达国家水平,值得临床高度关注。目前,国内尚无早产儿IVH预防的专家共识或指南,故中国医师协会新生儿科医师分会、北京医师协会新生儿专科医师分会组织专家,在参考国内外相关研究进展和诊疗指南基础上,制定《早产儿脑室内出血预防专家共识(2025)/Expert Consensuson Prevention of Intraventricular Hemorrhagein Preterm Infants(2025)》(以下简称为本共识),以规范早产儿IVH的预防和临床管理,从而降低早产儿IVH发生率,改善早产儿近、远期神经系统发育结局。 Intraventricular hemorrhage(IVH)in preterm infants is a significant complication leading to mortality and severe neurological disabilities,particularly in preterm infants with a gestational age<32 weeks.In recent years,the number of preterm infants receiving medical treatment in China has significantly increased,and the survival rates of very preterm infants(gestational age≥28-31 weeks)/extremely preterm infants(gestational age<28 weeks)have greatly improved.However,the incidence of IVH in extremely preterm infants remains high at 48%,with the occurrence of severe IVH showing an annual upward trend,markedly higher than that in developed countries,garnering significant attention.Currently,there is no expert consensus or guideline for the prevention of IVH in preterm infants within China.Therefore,the Neonatologist Branch of the Chinese Medical Doctor Association and the Neonatologist Branch of the Beijing Medical Doctor Association have organized experts to develop Expert Consensus on Prevention of Intraventricular Hemorrhage in Preterm Infants(2025)(hereinafter referred to as This Consensus).These initiatives in This Consensus is based on reference to relevant research progress and clinical guidelines both domestically and internationally,aiming to further standardize the prevention and clinical management of IVH in preterm infants,reduce the incidence of IVH,and improve both short-term and long-term neurological development outcomes for preterm infants.
作者 中国医师协会新生儿科医师分会 北京医师协会新生儿科医师分会 李秋平 封志纯 母得志 唐军 熊涛 唐尚鸿 Neonatal Physicians Branch of Chinese Medical Doctor Association;Neonatologist Branch of Beijing Medical Doctor Association;Li Qiuping;Feng Zhichun;Mu Dezhi;Tang Jun;Xiong Tao;Tang Shanghong(不详;Faculty of Pediatrics,Seventh Medical Center of Chinese PLA General Hospital,Beijing 100700,China;Department of Pediatrics,Key Laboratory of Birth Defects and Related Diseases of Women and Children(Sichuan University),West China Second University Hospital,Sichuan University,Chengdu 610041,Sichuan Province,China)
出处 《中华妇幼临床医学杂志(电子版)》 2025年第1期1-14,共14页 Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition)
基金 国家重点研发计划项目(2021YFC2700700、2021YFC2700702)。
关键词 脑出血 脑室内出血 临床管理 综合预防 神经系统疾病 专家共识 婴儿 超低出生体重 婴儿 早产 Cerebral hemorrhage Intraventricular hemorrhage Clinical governance Universal precautions Nervous system diseases Expert consensus Infant,extremely low birth weight Infant,preterm
  • 相关文献

参考文献3

二级参考文献16

  • 1Atkins D, Eccles M, Flottorp S, et al. Systems for grading the quality of evidence and the strength of recommendations I: critical appraisal of existing approaches. The GRADE Working Group. BMC Health ServRes, 2004, 4(1): 38.
  • 2Lacchetti C, Guyatt G. Surprising results of randomized trials. In: Guyatt G, Drummond R, eds. Users' guides to the medical literature: a manual of evidence-based clinical practice. Chicago, IL: AMA Press, 2002.
  • 3American College of Physicians. Guidelines for counseling postmenopausal women about preventive hormone therapy. Ann Intern Med, 1992, 117(12): 1038-1041.
  • 4Humphrey LL, Chan BK, Sox HC. Postmenopausal hormone replacement therapy and the primary prevention of cardiovascular disease. Ann Intern Med, 2002, 137(4): 273-284.
  • 5Hulley S, Grady D, Bush T, et al. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group. JAMA, 1998, 280(7): 605-613.
  • 6Rossouw JE, Anderson GL, Prentice RL, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA, 2002, 288(3): 321-333.
  • 7Echt DS, Liebson PR, Mitchell LB, et al. Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The cardiac arrhythmia suppression trial. N Engl J ivied, 1991,324( 12 ): 781-788.
  • 8Antman EM, Lau J, Kupelnick B, et al. A comparison of results of meta-analyses of randomized control trials and recommendations of clinical experts. Treatments for myocardial infarction, JAMA, 1992, 268(2): 240-248.
  • 9Committee on Infectious Diseases. Aspirin and Reye syndrome. Pediatrics, 1982, 69(6): 810-812.
  • 10Howard Balshem,Mark Helfanda,Holger J.Schunemann,Andrew D.Oxman,Regina Kunz,Jan Brozek,Gunn E.Vist,Yngve Falck-Ytter,Joerg Meerpohl,Susan Norris,Gordon H.Guyatt,GRADE工作组,李幼平,杨晓妍,高霑.GRADE指南:Ⅲ.证据质量分级[J].中国循证医学杂志,2011,11(4):451-455. 被引量:178

共引文献272

同被引文献27

引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部